Adjunctive Framework: Core & Supportive Modalities
Functional medicine approach integrated with ongoing neurological and rehabilitative care.
Cellular Therapy Component
Umbilical cord mesenchymal stem cells are used for their immunomodulatory and anti‑inflammatory properties. Objective: support neural tissue homeostasis and regulate neuroinflammation. Minimally invasive administration. Performed under physician supervision.
Explore Cellular TherapyPhysical Therapy Integration
Individualized physical rehabilitation protocol to maintain functional capacity, reduce spasticity, and support mobility. Integrated with regenerative therapy to improve quality of life. Evidence‑based, delivered by licensed therapists.
Explore Physical TherapyNutritional Medicine Support
Assessment of metabolic and nutritional status, targeted nutrition protocol focusing on anti‑inflammatory foods and mitochondrial support. Concurrent with conventional dietary management.
Explore Nutrition PlanTherapeutic Rationale: MSC Working Dynamics
The selection of umbilical cord‑derived mesenchymal stem cells is based on documented immunomodulatory and paracrine capabilities. These cells secrete bioactive molecules (cytokines, growth factors, exosomes) that influence the local neuroinflammatory environment.
When integrated with a structured physical therapy protocol (aimed at preserving function and reducing secondary complications) and a nutritional medicine protocol (targeting metabolic optimization), this approach represents a coordinated adjunctive strategy rather than a stand‑alone intervention.
Minimally invasive administration techniques are chosen to maximize cellular delivery while minimizing discomfort and procedural risk, consistent with contemporary medical practice for cellular therapies.
Scientific illustration
of paracrine signaling
Clinical Eligibility Considerations
Our clinical team evaluates several factors when assessing patients for this adjunctive approach. The following represent general considerations that guide patient evaluation:
- Documented diagnosis of cerebral palsy by a neurologist or developmental pediatrician
- Comprehensive medical evaluation to assess overall health status and inflammation markers
- Absence of contraindications to cellular therapy procedures
- Commitment to participate in all three components (MSC, physical therapy, nutrition)
- Realistic understanding of supportive goals: functional support, not a cure
- Willingness to undergo pre‑therapy assessments including GMFCS level
- Continuation of conventional cerebral palsy treatments (physical therapy, medications) under existing providers
Patients considering this adjunctive framework should maintain their current cerebral palsy management regimen (physical therapy, occupational therapy, medications if prescribed) until a complete evaluation and coordinated plan has been established with our medical team and their primary care providers.
Medical Director, Nexus Stem Cells
Dr. Guillermo Quezada, MD — Regenerative Medicine Specialist
Board-certified physician with extensive experience in cellular therapy protocols. Dr. Quezada leads our medical team in providing physician-supervised adjunctive frameworks grounded in current scientific evidence.
Meet Our ProvidersDownload Cerebral Palsy Resource Guide
Get our complimentary reference summary on MSC mechanisms, physical therapy integration, and nutritional support for cerebral palsy. No registration required.
Download Guide (PDF)No email or personal information required.